Task A02: Development of Lassa Virus infection Model for the Assessment of Anti-Viral Activity of Medical Interventions

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93024D00042-P00006-759302400006-1

Grant search

Key facts

  • Disease

    Lassa Haemorrhagic Fever
  • Start & end year

    2024
    2026
  • Known Financial Commitments (USD)

    $1,200,813
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    DAVID BEASLEY
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF TEXAS MED BR GALVESTON
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management
  • Research Subcategory

    Disease pathogenesis
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract

This contract provides for the development of new and refinement of existing models of infectious diseases and includes evaluation of candidate interventions.